Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, November 20, 2018
IQVIA announced Adhera Therapeutics has selected Orchestrated Customer Engagement (OCE) to build its commercial infrastructure and bring the company’s specialty drug innovations to patients.
read more
Monday, November 19, 2018
Adial Pharmaceuticals and Crown CRO announced Crown’s engagement to manage Adial’s Phase 3 clinical trial for AD04 for the treatment of alcohol use disorder.
read more
Adial and Tedor Pharma announced they entered into a collaboration agreement to provide cGMP contract manufacturing services for AD04.
read more
Adicet Bio has received a $10 million milestone payment from Regeneron associated with ADI-002 meeting key preclinical development goals.
read more
Wednesday, January 10, 2018
Adimab announced a multi-target partnership with Boehringer Ingelheim.
read more
Adimab has entered into an agreement with Eli Lilly to transfer the Adimab Platform to Lilly for the discovery and optimization of antibody-based drugs in all therapeutic areas.
read more
Adimab announced the expansion of an earlier multi-target research agreement with Regeneron Pharmaceuticals.
read more
Thursday, October 17, 2024
Adimab, LLC announced the appointment of Aaron Sato, Ph.D., to the newly created position of Chief Strategy Officer.
read more
Thursday, November 19, 2020
Adlib announced a rebrand that represents its evolution into an AI-driven, SaaS-based Content Intelligence and Contract Analytics business.
read more
ADMA Biologics Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, announced the commercial availability of additional vial sizes of BIVIGAM and NABI-HB, ...
read more
Tuesday, January 07, 2020
ADMA Biologics announced a five-year manufacturing and supply agreement to produce and sell plasma-derived intermediate fractions from ADMA’s FDA approved Immune Globulin manufacturing process.
read more
ADMA Biologics has commenced the collection of convalescent plasma through its wholly-owned subsidiary from individuals who have recovered from COVID-19.
read more
ADMA Biologics announced the commencement of operations and initiation of collections at its newest ADMA BioCenters plasma collection facility located in Knoxville, TN.
read more
Monday, December 14, 2020
ADMA Biologics announced commencement of operations and initiation of collections at its newest ADMA BioCenters plasma collection facility located in Maryville, Tennessee.
read more
ADMA Biologics, Inc. has announced commencement of operations and initiation of donor plasma collections at its newest ADMA BioCenters plasma collection facility located in Goose Creek, South Carolina.
read more